Retrieving NDC, package, manufacturer, and reference details.
Bivalirudin
15 indexed presentations.
Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.
Need a Product Not Listed?
Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.
Manufacturer identifiersManufacturer information is shown for product identification only.Endo USA, Inc. (2)MAIA Pharmaceuticals, Inc. (2)Meitheal Pharmaceuticals Inc. (2)Slate Run Pharmaceuticals, LLC (2)
Common dosage forms: Injection.
Common presentations
Compare presentation differences here, then open the table rows below for NDC-level confirmation.
Strength variation: 250 mg / 1 and 250 mg / 5mL.
Package variation: 1 Injection, Powder, Lyophilized, For Suspension, 1 Vial, Single-Dose, 10 Injection, Powder, Lyophilized, For Suspension, 10 Vial, Single-Dose, and 10 Vial, Single-Use.
Manufacturer information is shown for product identification only.
Official references
Use official label-search references for this generic family when your team needs supplemental labeling context.
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
